Inogen, Inc. NASDAQ:INGN

Founder-led company

Inogen stock price today

$7.49
-1.08
-12.7%
Financial Health
0
1
2
3
4
5
6
7
8
9

Inogen stock price monthly change

-4.77%
month

Inogen stock price quarterly change

-4.77%
quarter

Inogen stock price yearly change

+53.63%
year

Inogen key metrics

Market Cap
198.40M
Enterprise value
141.18M
P/E
-3.52
EV/Sales
0.39
EV/EBITDA
-1.30
Price/Sales
0.84
Price/Book
1.02
PEG ratio
N/A
EPS
-4.14
Revenue
321.52M
EBITDA
-11.11M
Income
-96.67M
Revenue Q/Q
8.12%
Revenue Y/Y
-12.87%
Profit margin
-37.83%
Oper. margin
-10.09%
Gross margin
37.78%
EBIT margin
-10.09%
EBITDA margin
-3.46%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Inogen stock price history

Inogen stock forecast

Inogen financial statements

Inogen, Inc. (NASDAQ:INGN): Profit margin
Jun 2023 83.63M -9.82M -11.75%
Sep 2023 83.96M -45.71M -54.45%
Dec 2023 75.89M -26.55M -34.99%
Mar 2024 78.02M -14.57M -18.68%
Inogen, Inc. (NASDAQ:INGN): Analyst Estimates
Sep 2025 90.66M -7.41M -8.18%
Oct 2025 88.50M -9.24M -10.44%
Dec 2025 82.55M -9.82M -11.91%
Mar 2026 82.29M -12.94M -15.73%
  • Analysts Price target

  • Financials & Ratios estimates

Inogen, Inc. (NASDAQ:INGN): Debt to assets
Jun 2023 374351000 99.57M 26.6%
Sep 2023 343696000 113.06M 32.9%
Dec 2023 326194000 121.38M 37.21%
Mar 2024 315599000 123.70M 39.2%
Inogen, Inc. (NASDAQ:INGN): Cash Flow
Jun 2023 4.03M -540K -33K
Sep 2023 2.18M -45.79M 448K
Dec 2023 -3.14M 4.12M -14K
Mar 2024 -4.74M -13.44M 285K

Inogen alternative data

Inogen, Inc. (NASDAQ:INGN): Employee count
Aug 2023 1,026
Sep 2023 1,026
Oct 2023 1,026
Nov 2023 1,026
Dec 2023 1,026
Jan 2024 1,026
Feb 2024 1,026
Mar 2024 834
Apr 2024 834
May 2024 834
Jun 2024 834
Jul 2024 834

Inogen other data

97.53% -1.08%
of INGN is owned by hedge funds
22.19M +14.57K
shares is hold by hedge funds

Inogen, Inc. (NASDAQ:INGN): Insider trades (number of shares)
Period Buy Sel
May 2024 0 10000
Transaction Date Insider Security Shares Price per share Total value Source
Option
SMITH KEVIN RAYMOND MERRILL director, officer: CEO and Pres..
Restricted Stock Unit 28,333 N/A N/A
Option
SMITH KEVIN RAYMOND MERRILL director, officer: CEO and Pres..
Common Stock 28,333 N/A N/A
Option
RAMADE GREGOIRE officer: Chief Co.. Restricted Stock Unit 31,565 N/A N/A
Option
RAMADE GREGOIRE officer: Chief Co.. Common Stock 31,565 N/A N/A
Option
SOMER JASON officer: EVP, Gen. Counsel & Se..
Common Stock 577 N/A N/A
Option
SOMER JASON officer: EVP, Gen. Counsel & Se..
Restricted Stock Unit 577 N/A N/A
Sale
SOMER JASON officer: EVP, Gen. Counsel & Se..
Common Stock 10,000 $8.56 $85,600
Option
GLEZER STANISLAV officer: EVP, R&D & Chief Med. ..
Restricted Stock Unit 32,638 N/A N/A
Option
SOMER JASON officer: EVP, Gen. Counsel & Se..
Common Stock 19,276 N/A N/A
Option
SOMER JASON officer: EVP, Gen. Counsel & Se..
Restricted Stock Unit 19,276 N/A N/A
Patent
Grant
Filling date: 1 Apr 2020 Issue date: 5 Apr 2022
Grant
Filling date: 17 Jun 2019 Issue date: 5 Apr 2022
Grant
Filling date: 1 Apr 2019 Issue date: 11 Jan 2022
Application
Filling date: 6 Aug 2021 Issue date: 25 Nov 2021
Grant
Filling date: 1 Apr 2019 Issue date: 14 Sep 2021
Grant
Filling date: 24 Feb 2020 Issue date: 7 Sep 2021
Application
Filling date: 18 Dec 2020 Issue date: 12 Aug 2021
Grant
Filling date: 30 May 2017 Issue date: 10 Aug 2021
Application
Filling date: 25 Sep 2020 Issue date: 18 Mar 2021
Application
Filling date: 5 Oct 2020 Issue date: 21 Jan 2021
Monday, 30 December 2024
businesswire.com
Tuesday, 24 December 2024
zacks.com
Thursday, 12 December 2024
zacks.com
Wednesday, 11 December 2024
zacks.com
Monday, 25 November 2024
zacks.com
Monday, 11 November 2024
zacks.com
Saturday, 9 November 2024
seekingalpha.com
Friday, 8 November 2024
zacks.com
Thursday, 7 November 2024
zacks.com
Friday, 18 October 2024
zacks.com
Thursday, 17 October 2024
businesswire.com
Friday, 4 October 2024
zacks.com
Monday, 16 September 2024
zacks.com
Thursday, 22 August 2024
zacks.com
Thursday, 8 August 2024
zacks.com
Wednesday, 7 August 2024
zacks.com
Tuesday, 6 August 2024
seekingalpha.com
zacks.com
Monday, 22 July 2024
investorplace.com
Monday, 15 July 2024
zacks.com
Wednesday, 3 July 2024
businesswire.com
Monday, 3 June 2024
businesswire.com
Thursday, 9 May 2024
Zacks Investment Research
Tuesday, 7 May 2024
Seeking Alpha
Zacks Investment Research
Thursday, 28 March 2024
Zacks Investment Research
Wednesday, 28 February 2024
Zacks Investment Research
Tuesday, 27 February 2024
Zacks Investment Research
Zacks Investment Research
Monday, 26 February 2024
Zacks Investment Research
  • What's the price of Inogen stock today?

    One share of Inogen stock can currently be purchased for approximately $7.49.

  • When is Inogen's next earnings date?

    Unfortunately, Inogen's (INGN) next earnings date is currently unknown.

  • Does Inogen pay dividends?

    No, Inogen does not pay dividends.

  • How much money does Inogen make?

    Inogen has a market capitalization of 198.40M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 16.32% to 315.66M US dollars.

  • What is Inogen's stock symbol?

    Inogen, Inc. is traded on the NASDAQ under the ticker symbol "INGN".

  • What is Inogen's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Inogen?

    Shares of Inogen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Inogen's key executives?

    Inogen's management team includes the following people:

    • Ms. Alison Perry Bauerlein Co-Founder(age: 44, pay: $373,490)
    • Mr. Bart Sanford Executive Vice President of Operations(age: 59, pay: $330,750)
  • Is Inogen founder-led company?

    Yes, Inogen is a company led by its founder Ms. Alison Perry Bauerlein.

  • How many employees does Inogen have?

    As Jul 2024, Inogen employs 834 workers.

  • When Inogen went public?

    Inogen, Inc. is publicly traded company for more then 11 years since IPO on 14 Feb 2014.

  • What is Inogen's official website?

    The official website for Inogen is inogen.com.

  • Where are Inogen's headquarters?

    Inogen is headquartered at 301 Coromar Drive, Goleta, CA.

  • How can i contact Inogen?

    Inogen's mailing address is 301 Coromar Drive, Goleta, CA and company can be reached via phone at 805 562 0500.

Inogen company profile:

Inogen, Inc.

inogen.com
Exchange:

NASDAQ

Full time employees:

834

Industry:

Medical - Devices

Sector:

Healthcare

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

301 Coromar Drive
Goleta, CA 93117

CIK: 0001294133
ISIN: US45780L1044
CUSIP: 45780L104